[1] 朱大岭,韩维娜,张荣.细胞色素P450系在药物代谢中的作用[J].医药导报, 2004,23(7):440-443. [2] 刘高峰,郭兴蕾.中药对细胞色素P450调控作用的研究进展[J].中草药,2008, 39(1):139-143. [3] 苏静华,孙建国,王广基. 药物诱导CYP450 的体外检测方法研究进展[J].中国临床药理学与治疗学,2010,15(8):954-960. [4] 于风平,连传宝.超快速液相色谱法测定刺五加注射液中紫丁香苷和绿原酸的含量[J].中国药师,2010,13(12):1769-1770. [5] Huang L, Zhao H, Huang B, et al. Acanthopanax senticosus: review of botany, chemistry and pharmacology[J]. Pharmazie,2010,66(2):83-97. [6] 范昕,刘锦森.刺五加注射液治疗失眠症的临床观察[J].中国药房,2011,22(4): 344-345. [7] 李广成,艾邵军.刺五加注射液治疗急性脑梗死临床观察[J].医学信息,2008,21 (12):2278-2280. [8] 郑家善,王忠东.刺五加注射液辅助治疗冠心病心绞痛疗效观察[J].中华全科医学,2009,7(3):276. [9] 李桂梅.刺五加注射液联合尼莫地平治疗急性缺血性脑卒中58例疗效观察[J].河北中医,2005,27(10):778-779. [10] 杨东威,王素梅,龚芹,等.刺五加注射液联用西药治疗类风湿关节炎临床观察[J].河北中医,2007,29(9):834-835. [11] 郑为超,胡顺金,王亿平,等.刺五加注射液合灯盏花素治疗早期糖尿病肾病临床观察[J].中医药临床杂志,2008,20(5):445-446. [12] 张廷芳. 酶促反应动力学[M] //王镜岩,朱长庚,徐长法 , 主编. 生物化学.3版.北京:高等教育出版社,2002:351-373. [13] Bjornsson TD, Callaghan JT, Einolf HJ, et al. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective [J]. Drug Metab Dispos,2003, 31(7):815-832. [14] Pan Y, Abd-Rashid BA, Ismail Z, et al. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica [J]. J Ethnopharmacol,2010,130(2):275-283. [15] Wang X, Cheung CM, Lee WY, et al. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro[J]. Phytomedicine, 2010,17(11): 868-875. [16] Walsky RL, Obach RS. Validated assays for human cytochrome P450 activities[J]. Drug Metab Dispos,2004,32(6):647-660. [17] Babbar S, Chanda S, Bley K. Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin[J]. Xenobiotica,2010,40(12):807-816. [18] Xia CH, Sun JG, Wang GJ, et al. Herb-drug interactions: in vivo and in vitro effect of Shenmai injection, a herbal preparation, on the metabolic activities of hepatic cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in rats[J]. Planta Med,2009,76(3):245-250. [19] Pelkonen O, Turpeinen M, Hakkola J, et al. Inhibition and induction of human cytochrome P450 enzymes: current status[J]. Arch Toxicol,2008,82(10): 667-715. [20] Fayer JL, Petullo DM, Ring BJ, et al. A novel testosterone 6 beta-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro[J]. J Pharmacol Toxicol Methods,2002,46(2):117-123. [21] 韩永龙,余奇,孟祥乐,等.灯盏细辛注射液对大鼠肝微粒体CYP3A的抑制作用[J].中国临床药理学与治疗学,2009,14(8):891-895. [22] Kramer MA, Tracy TS. Studying cytochrome P450 kinetics in drug metabolism[J]. Expert Opin Drug Metab Toxicol,2008,4(5):591-603. [23] Fowler S, Zhang H. In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions[J]. Aaps J,2008,10(2): 410-424. [24] Henderson GL, Harkey MR, Gershwin ME, et al.Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity[J]. Life Sci, 1999,65(15):209-214. [25] 张芳芳,郑一凡,祝慧娟,等.山奈酚和槲皮素对大鼠细胞色素P450酶活性的影响 [J].浙江大学学报(医学版),2006,35(1):18-22. [26] Li X, Choi JS. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats[J]. Anticancer Res,2009,29(4):1411-1415. [27] Umathe SN, Dixit PV, Kumar V, et al. Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition[J].Biochem Pharmacol,2008,75(8):1670-1676. [28] 李纳, 施孝金. 细胞色素P450酶基因多态性的研究进展及临床意义[J].中国临床药理学与治疗学,2009,14(10):1193-1200. [29] 中国国家处方集编委会. 肝脏细胞色素P450同工酶与药物代谢的影响[M] //金有豫,高润霖 主编.中国国家处方集.北京:人民军医出版社,2010:903. |